In conclusion, DKK1 contributes to HCC tumorigenesis by activating the Wnt/β-catenin signaling pathway, thus providing us with a potential therapeutic option for HCC in clinical practice. The gene discussed is DKK1; the disease is hepatocellular carcinoma.